Evidence-Based Medicine Guidelines
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Atorvastatin Vs Simvastatin or Pravastatin for Cholesterol Lowering in Primary Hypercholesterolemia and Mixed Dyslipidemias." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias.
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias. Accessed April 8, 2020.
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved April 08, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias
Atorvastatin Vs Simvastatin or Pravastatin for Cholesterol Lowering in Primary Hypercholesterolemia and Mixed Dyslipidemias [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 April 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias
ID - 454736
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -